Gilead Sciences (GILD) Accumulated Depreciation & Amortization (2009 - 2026)

Gilead Sciences has reported Accumulated Depreciation & Amortization for 18 years, with the latest figure at $2.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 9.52% year-over-year to $2.8 billion; the trailing twelve-month figure through Mar 2026 stood at $2.8 billion (up 9.52% YoY), and the FY2025 full-year result was $2.7 billion, up 9.15% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $2.8 billion, up from $2.7 billion in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $2.8 billion in Q1 2026, with the low at $2.2 billion in Q4 2022.
• Historically, Accumulated Depreciation & Amortization has averaged $2.6 billion across 5 years, with a median of $2.6 billion in 2025.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation & Amortization advanced 15.48% — and 2024, when it gained 0.86%.
• Gilead Sciences' Accumulated Depreciation & Amortization stood at $2.2 billion in 2022, then climbed by 12.03% to $2.4 billion in 2023, then gained by 0.86% to $2.5 billion in 2024, then grew by 9.15% to $2.7 billion in 2025, then climbed by 3.26% to $2.8 billion in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $2.8 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.